Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

trofosfamide MeSH Supplementary Concept Data 2026


MeSH Supplementary
trofosfamide
Unique ID
C003726
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C003726
Entry Term(s)
Genoxal Trofosfamida
Ixoten
N,N,N'-tris(2-chloroethyl)-N'-O-propylene phosphoric acid ester diamide
Z 4828
trophosphamide
Pharm Action
Immunosuppressive Agents
Mutagens
Antineoplastic Agents, Alkylating
Registry Numbers
H64JRU6GJ0
0
Related Numbers
22089-22-1
CAS Type 1 Name
N,N-3'-tris(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine, 2-oxide
Previous Indexing
*NITROGEN MUSTARD CPDS (72-78)
OXAZINES (72-78)
Heading Mapped to
Cyclophosphamide / analogs & derivatives
Frequency
114
Note
cyclophosphamide analog; structure
Source
Arzneim Forsch 25(9):1331;1975
Jpn J Clin Hematol 19(3):246;1978
MMW 121(22):760;1979
Mutat Res 32(3-4):331;1976
Mutat Res 33(2-3):221;1975
Naturwissenschaften 66(1):60;1979
Proc Soc Exp Biol Med 139(3):957;1972
S Afr Med J 53(22):886;1978
Date Introduced
1972/01/01
Last Updated
2014/10/28
trofosfamide Preferred
Z 4828 Narrower
Ixoten Narrower
Genoxal Trofosfamida Narrower
page delivered in 0.012s